MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
Year: 2026
Type: article
Source: Drug Resistance Updates
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: U.S. Department of Defense
OpenAlex ID: W7172094157
